Martin R. Farlow

Neurology

545 Barnhill Dr
Indianapolis, IN 46202

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 201 publications

Effect of Cognitive Reserve on Age at Symptom Onset and Cognitive Decline in Individuals With Dominantly Inherited Alzheimer Disease.

Effect of Cognitive Reserve on Age at Symptom Onset and Cognitive Decline in Individuals With Dominantly Inherited Alzheimer Disease.

Journal: Neurology

Published: April 08, 2026

The Indiana University Brain Health Program to deliver amyloid-targeted therapy to Alzheimer's disease patients.

The Indiana University Brain Health Program to deliver amyloid-targeted therapy to Alzheimer's disease patients.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: March 06, 2026

Systematic analysis of cellular cross-talk reveals a role for SEMA6D-TREM2 regulating microglial function in Alzheimer's disease.

Systematic analysis of cellular cross-talk reveals a role for SEMA6D-TREM2 regulating microglial function in Alzheimer's disease.

Journal: Science translational medicine

Published: July 30, 2025

The Cognitive Change Index in the Alzheimer's Disease Research Center setting: Self- and informant-ratings for perceived cognitive decline.

The Cognitive Change Index in the Alzheimer's Disease Research Center setting: Self- and informant-ratings for perceived cognitive decline.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: June 18, 2025

Validation of a MIND diet screener in older adults.

Validation of a MIND diet screener in older adults.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: May 19, 2025

Plasma proteomic analysis identifies proteins and pathways related to Alzheimer's risk.

Plasma proteomic analysis identifies proteins and pathways related to Alzheimer's risk.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: February 27, 2025

15 years of longitudinal genetic, clinical, cognitive, imaging, and biochemical measures in DIAN.

15 years of longitudinal genetic, clinical, cognitive, imaging, and biochemical measures in DIAN.

Journal: NPJ dementia

Published: January 23, 2025

Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.

Regional effects of gantenerumab on neuroimaging biomarkers in the DIAN-TU-001 trial.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: December 19, 2024

Association between BrainAGE and Alzheimer's disease biomarkers.

Association between BrainAGE and Alzheimer's disease biomarkers.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: October 16, 2024

Dynamic proportional loss of functional connectivity revealed change of left superior frontal gyrus in subjective cognitive decline: an explanatory study based on Chinese and Western cohorts.

Dynamic proportional loss of functional connectivity revealed change of left superior frontal gyrus in subjective cognitive decline: an explanatory study based on Chinese and Western cohorts.

Journal: GeroScience

Published: September 06, 2024

15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN.

15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN.

Journal: medRxiv : the preprint server for health sciences

Published: August 16, 2024

A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce.

A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce.

Journal: JAMA network open

Published: August 09, 2024

Showing 1-12 of 201

Last Updated: 09/26/2026